Your session is about to expire
← Back to Search
Mastering the World of Work for Mental Illness
N/A
Recruiting
Led By Zlatka Russinova, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Currently receiving supported employment services (Individual Placement and Support) at the Mental Health Center of Greater Manchester, in Manchester, NH
Age 18 or older
Must not have
Inability to give full and knowing consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new intervention called "Mastering the World of Work" to see if it can help improve employment outcomes for people with psychiatric disabilities who have trouble with things like forming a sense of self and others, and responding to challenges in life. The trial will be conducted with 60 people who are already receiving supported employment services, and will involve assessments at different points over 18 months.
Who is the study for?
This trial is for English-speaking adults over 18 with serious mental illness, including dual diagnosis, who are unemployed but receiving Supported Employment services in Manchester, NH. Participants must be willing to engage via Zoom and consent to audio recordings of sessions.
What is being tested?
The 'Mastering the World of Work' (MWW) intervention is being tested alongside usual Supported Employment services. The study will assess if MWW improves job outcomes for those with psychiatric disabilities and metacognitive deficits through a mix of remote and possibly in-person sessions.
What are the potential side effects?
Since MWW is a psychosocial intervention rather than a medication, it may not have typical medical side effects. However, participants might experience stress or discomfort discussing personal challenges during the program.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am getting job support services at the Mental Health Center in Manchester, NH.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand and give consent for treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Employment Rates
Employment Tenure
Secondary study objectives
Metacognition Assessment Scale - Abbreviated (MAS-A)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Study participants randomized to the experimental condition will receive IPS services as usual in conjunction with the MWW intervention.
Group II: ControlActive Control1 Intervention
Study participants randomized to the control condition will receive IPS services as usual.
Find a Location
Who is running the clinical trial?
Boston University Charles River CampusLead Sponsor
123 Previous Clinical Trials
13,997 Total Patients Enrolled
Zlatka Russinova, PhDPrincipal InvestigatorBoston University Center for Psychiatric Rehabilitation
2 Previous Clinical Trials
260 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to understand and give consent for treatment.I am getting job support services at the Mental Health Center in Manchester, NH.I can use Zoom for assessments and interventions if needed.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Experimental
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.